Hematology Seminar is organized by American Seminar Institute (ASI). 

Course(s) are appropriate for:
Family Practitioners, Pediatricians, Internists, General Practitioners, Nurses, Nurse Practitioners, and Physician Assistants (PA-C's)

Short Course: 
10 AMA PRA Category 1 Credits™ 

Short Course Price: $485

Series 2A (HEM2A) Topics Include: Favorable and Unfavorable Cytogenetic Profiles, Platelet and Bleeding Disorders, Evaluation of Children with Anemia, Oral Anticoagulant Agents, Patients with SAH or ICH, and more. 

Course Topics:
Hematologic Malignancies

Summarize favorable and unfavorable cytogenetic profiles observed in patients with myelodysplastic syndrome; List risks and benefits of drugs and antibodies commonly used to manage myelodysplastic syndrome; Counsel a patient with myelodysplastic syndrome who is contemplating stem cell transplantation; Weigh the risks and benefits of drugs and regimens commonly used to treat Waldenstrom macroglobulinemia; Assess the efficacy of ibrutinib for treatment of Waldenstrom macroglobulinemia.

Hematology and Oncology Review
Diagnose platelet and bleeding disorders using patient history and laboratory test results; Manage common coagulation and platelet disorders; Determine the cause of, and provide optimal treatment for, anemia; Explain the pathophysiology, clinical presentation, prognosis, and treatment of Hodgkin lymphoma and non-Hodgkin lymphoma Recognize the indications and contraindications for drugs used in the treatment of non-Hodgkin lymphoma.

Hematology Consultation
Treat anemia in pediatric patients; Explain the findings associated with thrombocytopenia in pediatric patients; Identify the most common causes of neutropenia in pediatric patients; Stratify causes of anemia based on stages of pediatric development; Choose the appropriate test(s) for evaluation of children with anemia.

Update on Anticoagulation
Weigh the advantages and disadvantages of warfarin and direct-acting oral anticoagulannt agents; Recognize indications for warfarin, direct-acting oral anticoagulant agents, and low-molecular-weight heparin; Employ American College of Chest Physicians guide-lines for antithrombotic therapy; Select appropriate agents for reversal of anticoagulation; Provide effective options to patients who cannot take direct-acting oral anticoagulant agents or warfarin for anticoagulation therapy and prevention of stroke.

Qualifies for Clinical Pharmacology

Bleeding and Hemorrhage
Identify patients who require reversal of NOACs; Select optimal reversal agents based on specific NOAC and patient characteristics; Determine which patients require workup for SAH based on suggestive clinical features and history; Set adequate targets for blood pressure control in patients with SAH or ICH; Initiate critical care interventions to reduce morbidity and mortality associated with SAH and ICH.

Intended Audience

Hematology Blood and Marrow Transplant

Activity Payment Details

Activity Fee : NA

Rate this CME (Min 1 - Max 5)

Fee and expenses:
CME credits:
Program contents:
Write Your Review

Reviews Given by Professionals

No Reviews available. Be the first to write a review.

Privacy Policy

Read eMedEvents Privacy Policy


American Seminar Institute (ASI)

View Organizer Details


866.611.5599, +1 855-763-2148, +1 970-963-1000